Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: Tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus

Transplantation

Volumn 83, Issue 10, 2007, Pages 1324-1329

  Gallon, Lorenzo G ^a,c   Winoto, Johan ^a   Chhabra, Darshika ^a   Parker, Michele A ^b   Leventhal, Joseph R ^a   Kaufman, Dixon B ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Galter Pavilion 17 200 ^*  (United States)

Author keywords

Kidney and pancreas transplantation; Prednisone free immunosuppression; Renal allograft function

Indexed keywords

COTRIMOXAZOLE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

ADULT; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DELAYED GRAFT FUNCTION; DEMOGRAPHY; DIARRHEA; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KAPLAN MEIER METHOD; KIDNEY ALLOGRAFT; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY INFECTION; KIDNEY PANCREAS TRANSPLANTATION; LEUKOPENIA; LYMPHOPROLIFERATIVE DISEASE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MYCOSIS; NEUTROPENIA; PANCREAS FUNCTION; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; PRIORITY JOURNAL; SEPSIS; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; URINARY TRACT INFECTION; WOUND HEALING IMPAIRMENT;

ADULT; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PANCREAS TRANSPLANTATION; RETROSPECTIVE STUDIES; SIROLIMUS; SURVIVAL ANALYSIS; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34249016276     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000264189.58324.91     Document Type: Article

References (25)

1. Becker BN, Brazy PC, Becker YT, et al. Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with end-stage renal disease. Kidney Int 2000; 57: 2129.
2. Bunnapradist S, Cho YW, Cecka JM, Wilkinson A, Danovitch GM. Kidney allograft and patient survival in type I diabetic recipients of cadaveric kidney alone versus simultaneous pancreas kidney transplants: A multivariate analysis of the UNOS database. J Am Soc Nephrol 2003; 14: 208.
3. Knoll GA, Nichol G. Dialysis, kidney transplantation, or pancreas transplantation for patients with diabetes mellitus and renal failure: A decision analysis of treatment options. J Am Soc Nephrol 2003; 14: 500.
4. Rayhill SC DAA, Odorico JS, Knechtle SJ, et al. Simultaneous pancreas-kidney transplantation and living related donor renal transplantation in patients with diabetes: Is there a difference in survival? Ann Surg 2000; 231: 417.
5. Tamajon LP, Miranda DM, Figueroa AC, et al. Improved cardiovascular risk profile of patients with type 1 diabetes mellitus and renal failure after simultaneous pancreas-kidney transplantation. Transplant Proc 2005; 37: 3979.
6. Matas AJ, McHugh L, Payne WD, et al. Long-term quality of life after kidney and simultaneous pancreas-kidney transplantation. Clin Transplant 1998; 12: 233.
7. Hathaway DK, Abell T, Cardoso S, Hartwig MS, el Gebely S, Gaber AO. Improvement in autonomic and gastric function following pancreas-kidney versus kidney-alone transplantation and the correlation with quality of life. Transplantation 1994; 57: 816.
8. Hathaway DK, Hartwig MS, Milstead J, Elmer D, Evans S, Gaber AO. Improvement in quality of life reported by diabetic recipients of kidney-only and pancreas-kidney allografts. Transplant Proc 1994; 26: 512.
9. Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 2005; 19: 433.
10. Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) cases reported to the United Network for Organ Sharing (UNOS) and non-US cases reported to the International Pancreas Transplant Registry (IPTR) as of October, 2000. Clin Transpl 2000; 45.
11. Ojo AO, Meier-Kriesche HU, Hanson JA, et al. The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation 2001; 71: 82.
12. Kaufman DB, Leventhal JR, Axelrod D, Gallon LG, Parker MA, Stuart FP. Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: Comparison with basiliximab induction-long-term results. Am J Transplant 2005; 5: 2539.
13. Kaufman DB, Leventhal JR, Gallon LG, Parker MA. Alemtuzumab induction and prednisone-free maintenance immunotherapy in simultaneous pancreas-kidney transplantation comparison with rabbit antithymocyte globulin induction - long-term results. Am J Transplant 2006; 6: 331.
14. Gallon LG, Leventhal J, Perico N, et al. Long-term renal allograft function on a Tacrolimus-based, Pred-free maintenance immunosuppression comparing Sirolimus vs. MMF. Am J Transplant 2006; 6: 1617.
15. Gaspari F, Ferrari S, Stucchi N, et al. Performance of different prediction equations for estimating renal function in kidney transplantation. Am J Transplant 2004; 4: 1826.
16. Poggio ED, Wang X, Weinstein DM, et al. Assessing glomerular filtration rate by equations in kidney transplant recipients. Am J Transplant 2006; 6: 100.
17. Levey AS, Bosh JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate: A new prediction equation modification of diet in renal disease study group. Ann Intern Med 1999; 130: 461.
18. Andoh TF, Lindsley J, Franceschini N, Bennett WM. Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model. Transplantation 1996; 62: 311.
19. Ninova D, Covarrubias M, Rea DJ, Park WD, Grande JP, Stegall MD. Acute nephrotoxicity of tacrolimus and sirolimus in renal isografts: Differential intragraft expression of transforming growth factor-beta1 and alpha-smooth muscle actin. Transplantation 2004; 78: 338.
20. Meier-Kriesche HU, Schold JD, Srinivas TR, Howard RJ, Fujita S, Kaplan B. Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus. Am J Transplant 2005; 5: 2273.
21. Wyner LM, McElroy JB, Hodge EE, Peidmonte M, Novick AC. Use of kidneys from older cadaver donors for renal transplantation. Urology 1993; 41: 107.
22. Leunissen KM, Bosman FT, Nieman FH, et al. Amplification of the nephrotoxic effect of cyclosporine by preexistent chronic histological lesions in the kidney. Transplantation 1989; 48: 590.
23. Zhong Z, Arteel GE, Connor HD, et al. Cyclosporin A increases hypoxia and free radical production in rat kidneys: prevention by dietary glycine. Am J Physiol 1998; 275: F595.
24. Zhou X, Yang G, Davis CA, et al. Hydrogen peroxide mediates FK506-induced cytotoxicity in renal cells. Kidney Int 2004; 65: 139.
25. Land WG. Ageing and immunosuppression in kidney transplantation. Exp Clin Transplant 2004; 2: 229.